Keryx Biopharmaceuticals Inc (KERX)

Add to Watchlists
Create an Alert
3.22 -0.10  -3.01% NASDAQ Oct 18, 16:08 Delayed 2m USD

Keryx Biopharmaceuticals Inc Shareholders Equity (Quarterly):

-41.19M for June 30, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Keryx Biopharmaceuticals Inc Shareholders Equity (Quarterly) Chart

Export Data
Save Image
Print Image

Keryx Biopharmaceuticals Inc Historical Shareholders Equity (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2018 -41.19M
March 31, 2018 -31.61M
Dec. 31, 2017 -14.10M
Sept. 30, 2017 8.962M
June 30, 2017 25.65M
March 31, 2017 -22.52M
Dec. 31, 2016 -8.296M
Sept. 30, 2016 21.99M
June 30, 2016 59.85M
March 31, 2016 49.40M
Dec. 31, 2015 86.93M
Sept. 30, 2015 121.07M
June 30, 2015 147.14M
March 31, 2015 168.54M
Dec. 31, 2014 73.48M
Sept. 30, 2014 98.71M
June 30, 2014 124.30M
March 31, 2014 143.92M
Dec. 31, 2013 45.40M
Sept. 30, 2013 58.57M
June 30, 2013 73.27M
March 31, 2013 83.87M
Dec. 31, 2012 10.49M
Sept. 30, 2012 16.58M
June 30, 2012 21.51M
   
March 31, 2012 22.58M
Dec. 31, 2011 31.05M
Sept. 30, 2011 38.89M
June 30, 2011 46.99M
March 31, 2011 17.42M
Dec. 31, 2010 23.25M
Sept. 30, 2010 27.71M
June 30, 2010 27.25M
March 31, 2010 28.55M
Dec. 31, 2009 32.10M
Sept. 30, 2009 34.96M
June 30, 2009 15.05M
March 31, 2009 -0.467M
Dec. 31, 2008 -1.489M
Sept. 30, 2008 0.321M
June 30, 2008 5.166M
March 31, 2008 10.84M
Dec. 31, 2007 44.42M
Sept. 30, 2007 71.12M
June 30, 2007 88.07M
March 31, 2007 105.12M
Dec. 31, 2006 123.82M
Sept. 30, 2006 140.79M
June 30, 2006 155.81M
March 31, 2006 164.57M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Shareholders' Equity

Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More

Advertisement

KERX Shareholders Equity (Quarterly) Benchmarks

Benchmarks
Akebia Therapeutics Inc 165.92M
Processa Pharmaceuticals Inc -0.0351M
Karyopharm Therapeutics Inc 213.47M

KERX Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum -41.19M Jun 2018
Maximum 168.54M Mar 2015
Average 55.66M

KERX Shareholders Equity (Quarterly) Excel Add-In Codes

  • Metric Code: shareholders_equity
  • Latest data point: =YCP("KERX", "shareholders_equity")
  • Last 5 data points: =YCS("KERX", "shareholders_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.